Inverse- Hold or Invest|8d IEF RSI vs 45d PSQ RSI + KMLM RSI
Today’s Change (Mar 18, 2026)
—
A symphony is an automated trading strategy — Learn more about symphonies here
About
Daily, stay in T‑Bills unless bonds look weak and the inverse Nasdaq trend is strong. If “on,” split between 3x inverse biotech (LABD) and 3x inverse long‑Treasuries (TMV) only when a trend gauge (KMLM) is strong; anything else sits in T‑Bills.
Each day it checks a simple 0–100 “recent strength” score (RSI). If 7–10y Treasuries (IEF, 8‑day score) look weaker than the 45‑day score of an inverse Nasdaq fund (PSQ), it tries inverse trades; otherwise it parks in T‑Bills (BIL).
When “on,” it buys: (1) a 3x bear biotech fund (LABD) and/or (2) a 3x bear long‑Treasury fund (TMV) only if each looks weak versus a trend barometer (KMLM, a managed‑futures ETF). It splits money equally among picks; anything not picked stays in BIL.
Out-of-sample, this strategy outperforms the S&P 500: ~31% annualized return vs ~19%, Sharpe 1.37 vs 1.14, Calmar 2.04, max drawdown 15% vs 19%. Higher returns with lower risk in a risk-managed sleeve.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
| Alpha | Beta | R2 | R | |
|---|---|---|---|---|
| 0.59 | -0.8 | 0.16 | -0.4 |
Performance Metrics
| Cumulative Return | Annualized Return | Trailing 1M Return | Trailing 3M Return | Sharpe Ratio | |
|---|---|---|---|---|---|
| 91.27% | 13.43% | -1.77% | 0.2% | 0.83 | |
| 764.31% | 52.05% | 5.6% | 9.71% | 1.41 |
Initial Investment
$10,000.00
Final Value
$86,431.29Regulatory Fees
$213.45
Total Slippage
$1,351.80
Invest in this strategy
OOS Start Date
Mar 18, 2024
Trading Setting
Daily
Type
Stocks
Category
Tactical allocation, inverse etfs, leveraged etfs, rsi momentum, trend-following, managed futures proxy, volatility filter, daily rebalance
Tickers in this symphonyThis symphony trades 6 assets in total
Ticker
Type